nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A5—Progesterone—uterine cancer	0.0917	0.229	CbGbCtD
Boceprevir—ABCB1—Progesterone—uterine cancer	0.0597	0.149	CbGbCtD
Boceprevir—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.054	0.135	CbGbCtD
Boceprevir—ABCB1—Dactinomycin—uterine cancer	0.0473	0.118	CbGbCtD
Boceprevir—CYP3A5—Etoposide—uterine cancer	0.041	0.102	CbGbCtD
Boceprevir—CYP3A4—Progesterone—uterine cancer	0.0358	0.0891	CbGbCtD
Boceprevir—ABCB1—Etoposide—uterine cancer	0.0267	0.0666	CbGbCtD
Boceprevir—ABCB1—Doxorubicin—uterine cancer	0.0182	0.0454	CbGbCtD
Boceprevir—CYP3A4—Etoposide—uterine cancer	0.016	0.0399	CbGbCtD
Boceprevir—CMA1—artery—uterine cancer	0.0126	0.0642	CbGeAlD
Boceprevir—CYP3A4—Doxorubicin—uterine cancer	0.0109	0.0272	CbGbCtD
Boceprevir—CTSL—exocrine gland—uterine cancer	0.0094	0.0479	CbGeAlD
Boceprevir—CTSV—myometrium—uterine cancer	0.00638	0.0325	CbGeAlD
Boceprevir—CTSS—exocrine gland—uterine cancer	0.00621	0.0316	CbGeAlD
Boceprevir—CTSL—myometrium—uterine cancer	0.00521	0.0265	CbGeAlD
Boceprevir—CTSV—uterine cervix—uterine cancer	0.00496	0.0253	CbGeAlD
Boceprevir—CTSV—decidua—uterine cancer	0.00473	0.0241	CbGeAlD
Boceprevir—CTSV—renal system—uterine cancer	0.00464	0.0236	CbGeAlD
Boceprevir—CMA1—smooth muscle tissue—uterine cancer	0.00461	0.0235	CbGeAlD
Boceprevir—CTSV—endometrium—uterine cancer	0.00449	0.0229	CbGeAlD
Boceprevir—CTSV—mammalian vulva—uterine cancer	0.00434	0.0221	CbGeAlD
Boceprevir—CMA1—mammalian vulva—uterine cancer	0.00415	0.0211	CbGeAlD
Boceprevir—CTSL—epithelium—uterine cancer	0.00409	0.0208	CbGeAlD
Boceprevir—CTSL—uterine cervix—uterine cancer	0.00405	0.0206	CbGeAlD
Boceprevir—CTSL—smooth muscle tissue—uterine cancer	0.00394	0.0201	CbGeAlD
Boceprevir—CTSK—myometrium—uterine cancer	0.00393	0.02	CbGeAlD
Boceprevir—CTSL—decidua—uterine cancer	0.00386	0.0197	CbGeAlD
Boceprevir—CTSL—renal system—uterine cancer	0.00379	0.0193	CbGeAlD
Boceprevir—CTSV—female reproductive system—uterine cancer	0.00372	0.0189	CbGeAlD
Boceprevir—CTSL—endometrium—uterine cancer	0.00367	0.0187	CbGeAlD
Boceprevir—CMA1—female reproductive system—uterine cancer	0.00355	0.0181	CbGeAlD
Boceprevir—CTSL—mammalian vulva—uterine cancer	0.00355	0.0181	CbGeAlD
Boceprevir—CTSS—myometrium—uterine cancer	0.00344	0.0175	CbGeAlD
Boceprevir—CTSV—female gonad—uterine cancer	0.00338	0.0172	CbGeAlD
Boceprevir—CTSL—uterus—uterine cancer	0.00338	0.0172	CbGeAlD
Boceprevir—CTSV—vagina—uterine cancer	0.00336	0.0171	CbGeAlD
Boceprevir—CTSK—uterine cervix—uterine cancer	0.00305	0.0156	CbGeAlD
Boceprevir—CTSL—female reproductive system—uterine cancer	0.00304	0.0155	CbGeAlD
Boceprevir—CTSK—smooth muscle tissue—uterine cancer	0.00297	0.0151	CbGeAlD
Boceprevir—CTSK—decidua—uterine cancer	0.00291	0.0148	CbGeAlD
Boceprevir—CTSK—renal system—uterine cancer	0.00286	0.0145	CbGeAlD
Boceprevir—CTSL—female gonad—uterine cancer	0.00276	0.0141	CbGeAlD
Boceprevir—CTSK—endometrium—uterine cancer	0.00276	0.0141	CbGeAlD
Boceprevir—CTSL—vagina—uterine cancer	0.00275	0.014	CbGeAlD
Boceprevir—CTSS—uterine cervix—uterine cancer	0.00268	0.0136	CbGeAlD
Boceprevir—CTSK—mammalian vulva—uterine cancer	0.00267	0.0136	CbGeAlD
Boceprevir—CTSS—smooth muscle tissue—uterine cancer	0.0026	0.0132	CbGeAlD
Boceprevir—CTSS—decidua—uterine cancer	0.00255	0.013	CbGeAlD
Boceprevir—CTSK—uterus—uterine cancer	0.00255	0.013	CbGeAlD
Boceprevir—CTSS—renal system—uterine cancer	0.0025	0.0127	CbGeAlD
Boceprevir—CTSS—endometrium—uterine cancer	0.00242	0.0123	CbGeAlD
Boceprevir—CTSS—mammalian vulva—uterine cancer	0.00234	0.0119	CbGeAlD
Boceprevir—CTSK—female reproductive system—uterine cancer	0.00229	0.0117	CbGeAlD
Boceprevir—CTSS—uterus—uterine cancer	0.00223	0.0114	CbGeAlD
Boceprevir—CTSK—female gonad—uterine cancer	0.00208	0.0106	CbGeAlD
Boceprevir—CMA1—lymph node—uterine cancer	0.00208	0.0106	CbGeAlD
Boceprevir—CTSK—vagina—uterine cancer	0.00207	0.0105	CbGeAlD
Boceprevir—CTSS—female reproductive system—uterine cancer	0.00201	0.0102	CbGeAlD
Boceprevir—CTSS—female gonad—uterine cancer	0.00182	0.00929	CbGeAlD
Boceprevir—CTSS—vagina—uterine cancer	0.00181	0.00923	CbGeAlD
Boceprevir—CTSL—lymph node—uterine cancer	0.00178	0.00905	CbGeAlD
Boceprevir—CTSK—lymph node—uterine cancer	0.00134	0.00682	CbGeAlD
Boceprevir—CTSS—lymph node—uterine cancer	0.00117	0.00597	CbGeAlD
Boceprevir—CYP3A5—uterine cervix—uterine cancer	0.000889	0.00453	CbGeAlD
Boceprevir—CYP3A5—renal system—uterine cancer	0.000832	0.00423	CbGeAlD
Boceprevir—CYP3A4—renal system—uterine cancer	0.000624	0.00318	CbGeAlD
Boceprevir—ABCB1—myometrium—uterine cancer	0.000607	0.00309	CbGeAlD
Boceprevir—CYP3A5—female gonad—uterine cancer	0.000606	0.00309	CbGeAlD
Boceprevir—CYP3A5—vagina—uterine cancer	0.000602	0.00307	CbGeAlD
Boceprevir—CYP3A4—female reproductive system—uterine cancer	0.0005	0.00254	CbGeAlD
Boceprevir—ABCB1—epithelium—uterine cancer	0.000476	0.00242	CbGeAlD
Boceprevir—ABCB1—uterine cervix—uterine cancer	0.000472	0.0024	CbGeAlD
Boceprevir—ABCB1—decidua—uterine cancer	0.00045	0.00229	CbGeAlD
Boceprevir—ABCB1—renal system—uterine cancer	0.000442	0.00225	CbGeAlD
Boceprevir—ABCB1—endometrium—uterine cancer	0.000427	0.00217	CbGeAlD
Boceprevir—ABCB1—mammalian vulva—uterine cancer	0.000413	0.0021	CbGeAlD
Boceprevir—ABCB1—uterus—uterine cancer	0.000394	0.002	CbGeAlD
Boceprevir—ABCB1—female reproductive system—uterine cancer	0.000354	0.0018	CbGeAlD
Boceprevir—ABCB1—female gonad—uterine cancer	0.000322	0.00164	CbGeAlD
Boceprevir—ABCB1—vagina—uterine cancer	0.00032	0.00163	CbGeAlD
Boceprevir—ABCB1—lymph node—uterine cancer	0.000207	0.00105	CbGeAlD
Boceprevir—Mood swings—Doxorubicin—uterine cancer	0.000202	0.000691	CcSEcCtD
Boceprevir—Infection—Etoposide—uterine cancer	0.0002	0.000686	CcSEcCtD
Boceprevir—Abdominal distension—Epirubicin—uterine cancer	0.0002	0.000685	CcSEcCtD
Boceprevir—Asthenia—Dactinomycin—uterine cancer	0.0002	0.000685	CcSEcCtD
Boceprevir—Influenza—Epirubicin—uterine cancer	0.000199	0.000681	CcSEcCtD
Boceprevir—Dysphagia—Epirubicin—uterine cancer	0.000199	0.000681	CcSEcCtD
Boceprevir—Dehydration—Doxorubicin—uterine cancer	0.000198	0.000678	CcSEcCtD
Boceprevir—Thrombocytopenia—Etoposide—uterine cancer	0.000197	0.000676	CcSEcCtD
Boceprevir—Tachycardia—Etoposide—uterine cancer	0.000197	0.000674	CcSEcCtD
Boceprevir—Eosinophilia—Epirubicin—uterine cancer	0.000197	0.000674	CcSEcCtD
Boceprevir—Skin disorder—Etoposide—uterine cancer	0.000196	0.000671	CcSEcCtD
Boceprevir—Dry skin—Doxorubicin—uterine cancer	0.000195	0.000668	CcSEcCtD
Boceprevir—Hyperhidrosis—Etoposide—uterine cancer	0.000195	0.000668	CcSEcCtD
Boceprevir—Pancreatitis—Epirubicin—uterine cancer	0.000195	0.000668	CcSEcCtD
Boceprevir—Abdominal pain upper—Doxorubicin—uterine cancer	0.000194	0.000666	CcSEcCtD
Boceprevir—Hypokalaemia—Doxorubicin—uterine cancer	0.000194	0.000663	CcSEcCtD
Boceprevir—Breast disorder—Doxorubicin—uterine cancer	0.000192	0.000659	CcSEcCtD
Boceprevir—Bronchitis—Epirubicin—uterine cancer	0.000191	0.000655	CcSEcCtD
Boceprevir—Diarrhoea—Dactinomycin—uterine cancer	0.000191	0.000653	CcSEcCtD
Boceprevir—Nasopharyngitis—Doxorubicin—uterine cancer	0.00019	0.000652	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	0.000189	0.00171	CbGpPWpGaD
Boceprevir—Pancytopenia—Epirubicin—uterine cancer	0.000189	0.000647	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—FGFR2—uterine cancer	0.000189	0.00171	CbGpPWpGaD
Boceprevir—Hypotension—Etoposide—uterine cancer	0.000188	0.000645	CcSEcCtD
Boceprevir—Gastritis—Doxorubicin—uterine cancer	0.000188	0.000645	CcSEcCtD
Boceprevir—Muscular weakness—Doxorubicin—uterine cancer	0.000188	0.000643	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	0.000186	0.00169	CbGpPWpGaD
Boceprevir—Neutropenia—Epirubicin—uterine cancer	0.000186	0.000637	CcSEcCtD
Boceprevir—Dysuria—Epirubicin—uterine cancer	0.000186	0.000637	CcSEcCtD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000185	0.00168	CbGpPWpGaD
Boceprevir—Abdominal distension—Doxorubicin—uterine cancer	0.000185	0.000634	CcSEcCtD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	0.000185	0.00167	CbGpPWpGaD
Boceprevir—Dysphagia—Doxorubicin—uterine cancer	0.000184	0.00063	CcSEcCtD
Boceprevir—Influenza—Doxorubicin—uterine cancer	0.000184	0.00063	CcSEcCtD
Boceprevir—Pollakiuria—Epirubicin—uterine cancer	0.000184	0.000629	CcSEcCtD
Boceprevir—Eosinophilia—Doxorubicin—uterine cancer	0.000182	0.000624	CcSEcCtD
Boceprevir—Photosensitivity reaction—Epirubicin—uterine cancer	0.000181	0.000621	CcSEcCtD
Boceprevir—Paraesthesia—Etoposide—uterine cancer	0.000181	0.00062	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—FGFR2—uterine cancer	0.000181	0.00164	CbGpPWpGaD
Boceprevir—Pancreatitis—Doxorubicin—uterine cancer	0.00018	0.000618	CcSEcCtD
Boceprevir—Weight decreased—Epirubicin—uterine cancer	0.00018	0.000616	CcSEcCtD
Boceprevir—Dyspnoea—Etoposide—uterine cancer	0.00018	0.000616	CcSEcCtD
Boceprevir—CTSS—Immune System—IRF1—uterine cancer	0.00018	0.00163	CbGpPWpGaD
Boceprevir—Hyperglycaemia—Epirubicin—uterine cancer	0.000179	0.000614	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	0.000178	0.00162	CbGpPWpGaD
Boceprevir—Pneumonia—Epirubicin—uterine cancer	0.000178	0.000611	CcSEcCtD
Boceprevir—Infestation—Epirubicin—uterine cancer	0.000177	0.000607	CcSEcCtD
Boceprevir—Infestation NOS—Epirubicin—uterine cancer	0.000177	0.000607	CcSEcCtD
Boceprevir—Vomiting—Dactinomycin—uterine cancer	0.000177	0.000607	CcSEcCtD
Boceprevir—Bronchitis—Doxorubicin—uterine cancer	0.000177	0.000606	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	0.000176	0.00159	CbGpPWpGaD
Boceprevir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000176	0.000602	CcSEcCtD
Boceprevir—Rash—Dactinomycin—uterine cancer	0.000176	0.000602	CcSEcCtD
Boceprevir—Decreased appetite—Etoposide—uterine cancer	0.000175	0.0006	CcSEcCtD
Boceprevir—Pancytopenia—Doxorubicin—uterine cancer	0.000175	0.000598	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000174	0.000596	CcSEcCtD
Boceprevir—Fatigue—Etoposide—uterine cancer	0.000174	0.000596	CcSEcCtD
Boceprevir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000174	0.000595	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—ERBB2—uterine cancer	0.000173	0.00157	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—ERBB2—uterine cancer	0.000173	0.00157	CbGpPWpGaD
Boceprevir—Stomatitis—Epirubicin—uterine cancer	0.000173	0.000592	CcSEcCtD
Boceprevir—Constipation—Etoposide—uterine cancer	0.000172	0.000591	CcSEcCtD
Boceprevir—Pain—Etoposide—uterine cancer	0.000172	0.000591	CcSEcCtD
Boceprevir—Conjunctivitis—Epirubicin—uterine cancer	0.000172	0.00059	CcSEcCtD
Boceprevir—Urinary tract infection—Epirubicin—uterine cancer	0.000172	0.00059	CcSEcCtD
Boceprevir—Dysuria—Doxorubicin—uterine cancer	0.000172	0.000589	CcSEcCtD
Boceprevir—Neutropenia—Doxorubicin—uterine cancer	0.000172	0.000589	CcSEcCtD
Boceprevir—Pollakiuria—Doxorubicin—uterine cancer	0.00017	0.000582	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—CCL2—uterine cancer	0.000169	0.00153	CbGpPWpGaD
Boceprevir—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000168	0.000575	CcSEcCtD
Boceprevir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000168	0.000574	CcSEcCtD
Boceprevir—Epistaxis—Epirubicin—uterine cancer	0.000167	0.000573	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—ERBB2—uterine cancer	0.000167	0.00151	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—ERBB2—uterine cancer	0.000167	0.00151	CbGpPWpGaD
Boceprevir—Weight decreased—Doxorubicin—uterine cancer	0.000166	0.00057	CcSEcCtD
Boceprevir—Sinusitis—Epirubicin—uterine cancer	0.000166	0.00057	CcSEcCtD
Boceprevir—Feeling abnormal—Etoposide—uterine cancer	0.000166	0.000569	CcSEcCtD
Boceprevir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000166	0.000568	CcSEcCtD
Boceprevir—Nausea—Dactinomycin—uterine cancer	0.000165	0.000567	CcSEcCtD
Boceprevir—Agranulocytosis—Epirubicin—uterine cancer	0.000165	0.000567	CcSEcCtD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000165	0.0015	CbGpPWpGaD
Boceprevir—Pneumonia—Doxorubicin—uterine cancer	0.000165	0.000565	CcSEcCtD
Boceprevir—Gastrointestinal pain—Etoposide—uterine cancer	0.000165	0.000565	CcSEcCtD
Boceprevir—Infestation—Doxorubicin—uterine cancer	0.000164	0.000562	CcSEcCtD
Boceprevir—Infestation NOS—Doxorubicin—uterine cancer	0.000164	0.000562	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CDH1—uterine cancer	0.000164	0.00148	CbGpPWpGaD
Boceprevir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000163	0.000557	CcSEcCtD
Boceprevir—CTSS—Immune System—FBXW7—uterine cancer	0.000161	0.00146	CbGpPWpGaD
Boceprevir—CTSL—Immune System—FGFR2—uterine cancer	0.000161	0.00146	CbGpPWpGaD
Boceprevir—CTSV—Immune System—FGFR2—uterine cancer	0.000161	0.00146	CbGpPWpGaD
Boceprevir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000161	0.000551	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—CDKN1B—uterine cancer	0.000161	0.00146	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—CDKN1B—uterine cancer	0.000161	0.00146	CbGpPWpGaD
Boceprevir—Urticaria—Etoposide—uterine cancer	0.00016	0.000549	CcSEcCtD
Boceprevir—CTSK—Immune System—SOCS3—uterine cancer	0.00016	0.00145	CbGpPWpGaD
Boceprevir—Stomatitis—Doxorubicin—uterine cancer	0.00016	0.000548	CcSEcCtD
Boceprevir—Rhinitis—Epirubicin—uterine cancer	0.000159	0.000546	CcSEcCtD
Boceprevir—Body temperature increased—Etoposide—uterine cancer	0.000159	0.000546	CcSEcCtD
Boceprevir—Abdominal pain—Etoposide—uterine cancer	0.000159	0.000546	CcSEcCtD
Boceprevir—Conjunctivitis—Doxorubicin—uterine cancer	0.000159	0.000546	CcSEcCtD
Boceprevir—Urinary tract infection—Doxorubicin—uterine cancer	0.000159	0.000546	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—AKR1C3—uterine cancer	0.000159	0.00144	CbGpPWpGaD
Boceprevir—Hypoaesthesia—Epirubicin—uterine cancer	0.000158	0.000542	CcSEcCtD
Boceprevir—Pharyngitis—Epirubicin—uterine cancer	0.000158	0.000541	CcSEcCtD
Boceprevir—Urinary tract disorder—Epirubicin—uterine cancer	0.000157	0.000538	CcSEcCtD
Boceprevir—Oedema peripheral—Epirubicin—uterine cancer	0.000157	0.000537	CcSEcCtD
Boceprevir—Connective tissue disorder—Epirubicin—uterine cancer	0.000156	0.000536	CcSEcCtD
Boceprevir—Urethral disorder—Epirubicin—uterine cancer	0.000156	0.000534	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	0.000156	0.00141	CbGpPWpGaD
Boceprevir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000155	0.000531	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—PGR—uterine cancer	0.000155	0.0014	CbGpPWpGaD
Boceprevir—Epistaxis—Doxorubicin—uterine cancer	0.000155	0.00053	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—CDKN1B—uterine cancer	0.000154	0.0014	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—CDKN1B—uterine cancer	0.000154	0.0014	CbGpPWpGaD
Boceprevir—Sinusitis—Doxorubicin—uterine cancer	0.000154	0.000527	CcSEcCtD
Boceprevir—Visual impairment—Epirubicin—uterine cancer	0.000153	0.000525	CcSEcCtD
Boceprevir—Agranulocytosis—Doxorubicin—uterine cancer	0.000153	0.000524	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—CTNNB1—uterine cancer	0.000152	0.00138	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—CTNNB1—uterine cancer	0.000152	0.00138	CbGpPWpGaD
Boceprevir—Erythema multiforme—Epirubicin—uterine cancer	0.00015	0.000515	CcSEcCtD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.00015	0.00136	CbGpPWpGaD
Boceprevir—Eye disorder—Epirubicin—uterine cancer	0.000149	0.000509	CcSEcCtD
Boceprevir—Hypersensitivity—Etoposide—uterine cancer	0.000149	0.000509	CcSEcCtD
Boceprevir—Tinnitus—Epirubicin—uterine cancer	0.000148	0.000508	CcSEcCtD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000148	0.00134	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PTEN—uterine cancer	0.000148	0.00134	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PTEN—uterine cancer	0.000148	0.00134	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—YWHAE—uterine cancer	0.000148	0.00134	CbGpPWpGaD
Boceprevir—Cardiac disorder—Epirubicin—uterine cancer	0.000148	0.000506	CcSEcCtD
Boceprevir—Flushing—Epirubicin—uterine cancer	0.000148	0.000506	CcSEcCtD
Boceprevir—Rhinitis—Doxorubicin—uterine cancer	0.000148	0.000506	CcSEcCtD
Boceprevir—Hypoaesthesia—Doxorubicin—uterine cancer	0.000146	0.000502	CcSEcCtD
Boceprevir—Pharyngitis—Doxorubicin—uterine cancer	0.000146	0.0005	CcSEcCtD
Boceprevir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000145	0.000498	CcSEcCtD
Boceprevir—Oedema peripheral—Doxorubicin—uterine cancer	0.000145	0.000497	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	0.000145	0.00131	CbGpPWpGaD
Boceprevir—Asthenia—Etoposide—uterine cancer	0.000145	0.000496	CcSEcCtD
Boceprevir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000145	0.000496	CcSEcCtD
Boceprevir—Angiopathy—Epirubicin—uterine cancer	0.000144	0.000494	CcSEcCtD
Boceprevir—Urethral disorder—Doxorubicin—uterine cancer	0.000144	0.000494	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—ERBB2—uterine cancer	0.000144	0.0013	CbGpPWpGaD
Boceprevir—Immune system disorder—Epirubicin—uterine cancer	0.000144	0.000492	CcSEcCtD
Boceprevir—Mediastinal disorder—Epirubicin—uterine cancer	0.000143	0.000491	CcSEcCtD
Boceprevir—Chills—Epirubicin—uterine cancer	0.000143	0.000489	CcSEcCtD
Boceprevir—Pruritus—Etoposide—uterine cancer	0.000143	0.000489	CcSEcCtD
Boceprevir—Arrhythmia—Epirubicin—uterine cancer	0.000142	0.000487	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—PTEN—uterine cancer	0.000142	0.00129	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PTEN—uterine cancer	0.000142	0.00129	CbGpPWpGaD
Boceprevir—Visual impairment—Doxorubicin—uterine cancer	0.000142	0.000486	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—FBXW7—uterine cancer	0.000142	0.00128	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—EP300—uterine cancer	0.000141	0.00128	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—EP300—uterine cancer	0.000141	0.00128	CbGpPWpGaD
Boceprevir—Alopecia—Epirubicin—uterine cancer	0.000141	0.000482	CcSEcCtD
Boceprevir—Mental disorder—Epirubicin—uterine cancer	0.000139	0.000477	CcSEcCtD
Boceprevir—Erythema multiforme—Doxorubicin—uterine cancer	0.000139	0.000477	CcSEcCtD
Boceprevir—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	0.000139	0.00126	CbGpPWpGaD
Boceprevir—Erythema—Epirubicin—uterine cancer	0.000138	0.000474	CcSEcCtD
Boceprevir—Malnutrition—Epirubicin—uterine cancer	0.000138	0.000474	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—ERBB2—uterine cancer	0.000138	0.00125	CbGpPWpGaD
Boceprevir—Diarrhoea—Etoposide—uterine cancer	0.000138	0.000473	CcSEcCtD
Boceprevir—Eye disorder—Doxorubicin—uterine cancer	0.000138	0.000471	CcSEcCtD
Boceprevir—Tinnitus—Doxorubicin—uterine cancer	0.000137	0.00047	CcSEcCtD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	0.000137	0.00124	CbGpPWpGaD
Boceprevir—Flushing—Doxorubicin—uterine cancer	0.000137	0.000468	CcSEcCtD
Boceprevir—Cardiac disorder—Doxorubicin—uterine cancer	0.000137	0.000468	CcSEcCtD
Boceprevir—Flatulence—Epirubicin—uterine cancer	0.000136	0.000467	CcSEcCtD
Boceprevir—Dysgeusia—Epirubicin—uterine cancer	0.000136	0.000465	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CDH1—uterine cancer	0.000135	0.00122	CbGpPWpGaD
Boceprevir—Back pain—Epirubicin—uterine cancer	0.000134	0.000459	CcSEcCtD
Boceprevir—CMA1—Metabolism of proteins—CXCL8—uterine cancer	0.000134	0.00121	CbGpPWpGaD
Boceprevir—Angiopathy—Doxorubicin—uterine cancer	0.000134	0.000458	CcSEcCtD
Boceprevir—Dizziness—Etoposide—uterine cancer	0.000133	0.000457	CcSEcCtD
Boceprevir—CTSK—Immune System—FGFR2—uterine cancer	0.000133	0.00121	CbGpPWpGaD
Boceprevir—Muscle spasms—Epirubicin—uterine cancer	0.000133	0.000456	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CDKN1B—uterine cancer	0.000133	0.00121	CbGpPWpGaD
Boceprevir—Immune system disorder—Doxorubicin—uterine cancer	0.000133	0.000455	CcSEcCtD
Boceprevir—Mediastinal disorder—Doxorubicin—uterine cancer	0.000133	0.000454	CcSEcCtD
Boceprevir—Chills—Doxorubicin—uterine cancer	0.000132	0.000452	CcSEcCtD
Boceprevir—CTSV—Innate Immune System—NRAS—uterine cancer	0.000132	0.0012	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—NRAS—uterine cancer	0.000132	0.0012	CbGpPWpGaD
Boceprevir—CTSS—Immune System—SOCS3—uterine cancer	0.000132	0.00119	CbGpPWpGaD
Boceprevir—Arrhythmia—Doxorubicin—uterine cancer	0.000132	0.00045	CcSEcCtD
Boceprevir—Vision blurred—Epirubicin—uterine cancer	0.000131	0.000447	CcSEcCtD
Boceprevir—Alopecia—Doxorubicin—uterine cancer	0.00013	0.000446	CcSEcCtD
Boceprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	0.00013	0.00118	CbGpPWpGaD
Boceprevir—Mental disorder—Doxorubicin—uterine cancer	0.000129	0.000442	CcSEcCtD
Boceprevir—Ill-defined disorder—Epirubicin—uterine cancer	0.000128	0.00044	CcSEcCtD
Boceprevir—Vomiting—Etoposide—uterine cancer	0.000128	0.000439	CcSEcCtD
Boceprevir—Malnutrition—Doxorubicin—uterine cancer	0.000128	0.000439	CcSEcCtD
Boceprevir—Erythema—Doxorubicin—uterine cancer	0.000128	0.000439	CcSEcCtD
Boceprevir—Anaemia—Epirubicin—uterine cancer	0.000128	0.000438	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—CDKN1B—uterine cancer	0.000128	0.00116	CbGpPWpGaD
Boceprevir—Agitation—Epirubicin—uterine cancer	0.000127	0.000436	CcSEcCtD
Boceprevir—Rash—Etoposide—uterine cancer	0.000127	0.000436	CcSEcCtD
Boceprevir—Dermatitis—Etoposide—uterine cancer	0.000127	0.000435	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—NRAS—uterine cancer	0.000127	0.00115	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—NRAS—uterine cancer	0.000127	0.00115	CbGpPWpGaD
Boceprevir—Headache—Etoposide—uterine cancer	0.000126	0.000433	CcSEcCtD
Boceprevir—Flatulence—Doxorubicin—uterine cancer	0.000126	0.000433	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—CTNNB1—uterine cancer	0.000126	0.00114	CbGpPWpGaD
Boceprevir—Dysgeusia—Doxorubicin—uterine cancer	0.000125	0.00043	CcSEcCtD
Boceprevir—Malaise—Epirubicin—uterine cancer	0.000125	0.000428	CcSEcCtD
Boceprevir—Vertigo—Epirubicin—uterine cancer	0.000124	0.000426	CcSEcCtD
Boceprevir—Syncope—Epirubicin—uterine cancer	0.000124	0.000425	CcSEcCtD
Boceprevir—Leukopenia—Epirubicin—uterine cancer	0.000124	0.000425	CcSEcCtD
Boceprevir—Back pain—Doxorubicin—uterine cancer	0.000124	0.000425	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—STK11—uterine cancer	0.000124	0.00112	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—CTNNB1—uterine cancer	0.000123	0.00112	CbGpPWpGaD
Boceprevir—Muscle spasms—Doxorubicin—uterine cancer	0.000123	0.000422	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—PTEN—uterine cancer	0.000123	0.00111	CbGpPWpGaD
Boceprevir—Palpitations—Epirubicin—uterine cancer	0.000122	0.000419	CcSEcCtD
Boceprevir—Loss of consciousness—Epirubicin—uterine cancer	0.000122	0.000417	CcSEcCtD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000122	0.0011	CbGpPWpGaD
Boceprevir—Cough—Epirubicin—uterine cancer	0.000121	0.000414	CcSEcCtD
Boceprevir—Vision blurred—Doxorubicin—uterine cancer	0.000121	0.000414	CcSEcCtD
Boceprevir—Nausea—Etoposide—uterine cancer	0.00012	0.00041	CcSEcCtD
Boceprevir—CTSV—Immune System—CDH1—uterine cancer	0.00012	0.00109	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CDH1—uterine cancer	0.00012	0.00109	CbGpPWpGaD
Boceprevir—Hypertension—Epirubicin—uterine cancer	0.00012	0.00041	CcSEcCtD
Boceprevir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000119	0.000407	CcSEcCtD
Boceprevir—Anaemia—Doxorubicin—uterine cancer	0.000118	0.000406	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—ERBB2—uterine cancer	0.000118	0.00107	CbGpPWpGaD
Boceprevir—Chest pain—Epirubicin—uterine cancer	0.000118	0.000404	CcSEcCtD
Boceprevir—Myalgia—Epirubicin—uterine cancer	0.000118	0.000404	CcSEcCtD
Boceprevir—Arthralgia—Epirubicin—uterine cancer	0.000118	0.000404	CcSEcCtD
Boceprevir—Agitation—Doxorubicin—uterine cancer	0.000118	0.000403	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—PTEN—uterine cancer	0.000118	0.00107	CbGpPWpGaD
Boceprevir—Anxiety—Epirubicin—uterine cancer	0.000117	0.000402	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000117	0.000401	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—EP300—uterine cancer	0.000117	0.00106	CbGpPWpGaD
Boceprevir—Discomfort—Epirubicin—uterine cancer	0.000116	0.000399	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SOCS3—uterine cancer	0.000116	0.00105	CbGpPWpGaD
Boceprevir—Malaise—Doxorubicin—uterine cancer	0.000116	0.000396	CcSEcCtD
Boceprevir—Dry mouth—Epirubicin—uterine cancer	0.000115	0.000395	CcSEcCtD
Boceprevir—Vertigo—Doxorubicin—uterine cancer	0.000115	0.000394	CcSEcCtD
Boceprevir—Syncope—Doxorubicin—uterine cancer	0.000115	0.000394	CcSEcCtD
Boceprevir—Leukopenia—Doxorubicin—uterine cancer	0.000115	0.000393	CcSEcCtD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	0.000115	0.00104	CbGpPWpGaD
Boceprevir—Confusional state—Epirubicin—uterine cancer	0.000114	0.00039	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—ERBB2—uterine cancer	0.000114	0.00103	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—KRAS—uterine cancer	0.000114	0.00103	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—KRAS—uterine cancer	0.000114	0.00103	CbGpPWpGaD
Boceprevir—Palpitations—Doxorubicin—uterine cancer	0.000113	0.000388	CcSEcCtD
Boceprevir—Loss of consciousness—Doxorubicin—uterine cancer	0.000113	0.000386	CcSEcCtD
Boceprevir—Infection—Epirubicin—uterine cancer	0.000112	0.000385	CcSEcCtD
Boceprevir—Cough—Doxorubicin—uterine cancer	0.000112	0.000383	CcSEcCtD
Boceprevir—Shock—Epirubicin—uterine cancer	0.000111	0.000381	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CDKN2B—uterine cancer	0.000111	0.00101	CbGpPWpGaD
Boceprevir—Nervous system disorder—Epirubicin—uterine cancer	0.000111	0.00038	CcSEcCtD
Boceprevir—Thrombocytopenia—Epirubicin—uterine cancer	0.000111	0.000379	CcSEcCtD
Boceprevir—Hypertension—Doxorubicin—uterine cancer	0.000111	0.000379	CcSEcCtD
Boceprevir—Tachycardia—Epirubicin—uterine cancer	0.00011	0.000378	CcSEcCtD
Boceprevir—CTSS—Immune System—FGFR2—uterine cancer	0.00011	0.000995	CbGpPWpGaD
Boceprevir—Skin disorder—Epirubicin—uterine cancer	0.00011	0.000376	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CDKN1B—uterine cancer	0.00011	0.000993	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—NRAS—uterine cancer	0.000109	0.000991	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Epirubicin—uterine cancer	0.000109	0.000374	CcSEcCtD
Boceprevir—Arthralgia—Doxorubicin—uterine cancer	0.000109	0.000374	CcSEcCtD
Boceprevir—Myalgia—Doxorubicin—uterine cancer	0.000109	0.000374	CcSEcCtD
Boceprevir—Chest pain—Doxorubicin—uterine cancer	0.000109	0.000374	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—KRAS—uterine cancer	0.000109	0.000988	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—KRAS—uterine cancer	0.000109	0.000988	CbGpPWpGaD
Boceprevir—Anxiety—Doxorubicin—uterine cancer	0.000109	0.000372	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000108	0.000371	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—IGF1R—uterine cancer	0.000108	0.000977	CbGpPWpGaD
Boceprevir—Discomfort—Doxorubicin—uterine cancer	0.000108	0.000369	CcSEcCtD
Boceprevir—Dry mouth—Doxorubicin—uterine cancer	0.000107	0.000365	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	0.000106	0.000962	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	0.000106	0.000962	CbGpPWpGaD
Boceprevir—Hypotension—Epirubicin—uterine cancer	0.000106	0.000362	CcSEcCtD
Boceprevir—Confusional state—Doxorubicin—uterine cancer	0.000105	0.000361	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—CDKN1B—uterine cancer	0.000105	0.000954	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—NRAS—uterine cancer	0.000105	0.000952	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—PIK3CA—uterine cancer	0.000104	0.000946	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—PIK3CA—uterine cancer	0.000104	0.000946	CbGpPWpGaD
Boceprevir—Infection—Doxorubicin—uterine cancer	0.000104	0.000356	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—CTNNB1—uterine cancer	0.000104	0.000939	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000103	0.000353	CcSEcCtD
Boceprevir—Shock—Doxorubicin—uterine cancer	0.000103	0.000352	CcSEcCtD
Boceprevir—Nervous system disorder—Doxorubicin—uterine cancer	0.000103	0.000351	CcSEcCtD
Boceprevir—Thrombocytopenia—Doxorubicin—uterine cancer	0.000102	0.000351	CcSEcCtD
Boceprevir—Insomnia—Epirubicin—uterine cancer	0.000102	0.00035	CcSEcCtD
Boceprevir—Tachycardia—Doxorubicin—uterine cancer	0.000102	0.00035	CcSEcCtD
Boceprevir—Skin disorder—Doxorubicin—uterine cancer	0.000102	0.000348	CcSEcCtD
Boceprevir—Paraesthesia—Epirubicin—uterine cancer	0.000101	0.000348	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—SMAD3—uterine cancer	0.000101	0.000919	CbGpPWpGaD
Boceprevir—Hyperhidrosis—Doxorubicin—uterine cancer	0.000101	0.000346	CcSEcCtD
Boceprevir—CTSV—Immune System—ERBB2—uterine cancer	0.000101	0.000916	CbGpPWpGaD
Boceprevir—CTSL—Immune System—ERBB2—uterine cancer	0.000101	0.000916	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—PTEN—uterine cancer	0.000101	0.000915	CbGpPWpGaD
Boceprevir—Dyspnoea—Epirubicin—uterine cancer	0.000101	0.000345	CcSEcCtD
Boceprevir—CTSV—Adaptive Immune System—PIK3CA—uterine cancer	0.0001	0.000908	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—PIK3CA—uterine cancer	0.0001	0.000908	CbGpPWpGaD
Boceprevir—Dyspepsia—Epirubicin—uterine cancer	9.95e-05	0.000341	CcSEcCtD
Boceprevir—CTSK—Immune System—CDH1—uterine cancer	9.92e-05	0.000899	CbGpPWpGaD
Boceprevir—Decreased appetite—Epirubicin—uterine cancer	9.83e-05	0.000337	CcSEcCtD
Boceprevir—Hypotension—Doxorubicin—uterine cancer	9.77e-05	0.000335	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Epirubicin—uterine cancer	9.76e-05	0.000334	CcSEcCtD
Boceprevir—Fatigue—Epirubicin—uterine cancer	9.74e-05	0.000334	CcSEcCtD
Boceprevir—CTSS—Adaptive Immune System—PTEN—uterine cancer	9.69e-05	0.000878	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGFR2—uterine cancer	9.67e-05	0.000876	CbGpPWpGaD
Boceprevir—Constipation—Epirubicin—uterine cancer	9.67e-05	0.000331	CcSEcCtD
Boceprevir—Pain—Epirubicin—uterine cancer	9.67e-05	0.000331	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—HRAS—uterine cancer	9.66e-05	0.000875	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—HRAS—uterine cancer	9.66e-05	0.000875	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	9.64e-05	0.000873	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—EP300—uterine cancer	9.63e-05	0.000872	CbGpPWpGaD
Boceprevir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.53e-05	0.000326	CcSEcCtD
Boceprevir—Insomnia—Doxorubicin—uterine cancer	9.46e-05	0.000324	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—KRAS—uterine cancer	9.41e-05	0.000853	CbGpPWpGaD
Boceprevir—Paraesthesia—Doxorubicin—uterine cancer	9.39e-05	0.000322	CcSEcCtD
Boceprevir—CTSL—Immune System—CDKN1B—uterine cancer	9.36e-05	0.000848	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CDKN1B—uterine cancer	9.36e-05	0.000848	CbGpPWpGaD
Boceprevir—Dyspnoea—Doxorubicin—uterine cancer	9.32e-05	0.000319	CcSEcCtD
Boceprevir—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	9.32e-05	0.000845	CbGpPWpGaD
Boceprevir—Feeling abnormal—Epirubicin—uterine cancer	9.31e-05	0.000319	CcSEcCtD
Boceprevir—CTSL—Adaptive Immune System—HRAS—uterine cancer	9.27e-05	0.00084	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—HRAS—uterine cancer	9.27e-05	0.00084	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Epirubicin—uterine cancer	9.24e-05	0.000317	CcSEcCtD
Boceprevir—Dyspepsia—Doxorubicin—uterine cancer	9.21e-05	0.000315	CcSEcCtD
Boceprevir—Decreased appetite—Doxorubicin—uterine cancer	9.09e-05	0.000311	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—CXCL8—uterine cancer	9.08e-05	0.000823	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—KRAS—uterine cancer	9.04e-05	0.000819	CbGpPWpGaD
Boceprevir—Gastrointestinal disorder—Doxorubicin—uterine cancer	9.03e-05	0.000309	CcSEcCtD
Boceprevir—Fatigue—Doxorubicin—uterine cancer	9.02e-05	0.000309	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—NRAS—uterine cancer	9.01e-05	0.000816	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	8.99e-05	0.000815	CbGpPWpGaD
Boceprevir—Urticaria—Epirubicin—uterine cancer	8.98e-05	0.000308	CcSEcCtD
Boceprevir—Constipation—Doxorubicin—uterine cancer	8.94e-05	0.000306	CcSEcCtD
Boceprevir—Pain—Doxorubicin—uterine cancer	8.94e-05	0.000306	CcSEcCtD
Boceprevir—Abdominal pain—Epirubicin—uterine cancer	8.94e-05	0.000306	CcSEcCtD
Boceprevir—Body temperature increased—Epirubicin—uterine cancer	8.94e-05	0.000306	CcSEcCtD
Boceprevir—CTSV—Immune System—CTNNB1—uterine cancer	8.84e-05	0.000801	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CTNNB1—uterine cancer	8.84e-05	0.000801	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	8.78e-05	0.000795	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.69e-05	0.000788	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	8.66e-05	0.000784	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRAS—uterine cancer	8.65e-05	0.000784	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—PIK3CA—uterine cancer	8.65e-05	0.000784	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	8.64e-05	0.000783	CbGpPWpGaD
Boceprevir—Feeling abnormal—Doxorubicin—uterine cancer	8.62e-05	0.000295	CcSEcCtD
Boceprevir—CTSV—Immune System—PTEN—uterine cancer	8.62e-05	0.000781	CbGpPWpGaD
Boceprevir—CTSL—Immune System—PTEN—uterine cancer	8.62e-05	0.000781	CbGpPWpGaD
Boceprevir—Gastrointestinal pain—Doxorubicin—uterine cancer	8.55e-05	0.000293	CcSEcCtD
Boceprevir—CTSL—Innate Immune System—AKT1—uterine cancer	8.53e-05	0.000773	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—uterine cancer	8.53e-05	0.000773	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	8.52e-05	0.000772	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ERBB2—uterine cancer	8.37e-05	0.000759	CbGpPWpGaD
Boceprevir—Hypersensitivity—Epirubicin—uterine cancer	8.33e-05	0.000285	CcSEcCtD
Boceprevir—Urticaria—Doxorubicin—uterine cancer	8.31e-05	0.000285	CcSEcCtD
Boceprevir—CTSK—Adaptive Immune System—PIK3CA—uterine cancer	8.3e-05	0.000753	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ESR1—uterine cancer	8.28e-05	0.00075	CbGpPWpGaD
Boceprevir—Body temperature increased—Doxorubicin—uterine cancer	8.27e-05	0.000283	CcSEcCtD
Boceprevir—Abdominal pain—Doxorubicin—uterine cancer	8.27e-05	0.000283	CcSEcCtD
Boceprevir—CTSL—Immune System—EP300—uterine cancer	8.22e-05	0.000745	CbGpPWpGaD
Boceprevir—CTSV—Immune System—EP300—uterine cancer	8.22e-05	0.000745	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—uterine cancer	8.19e-05	0.000742	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—uterine cancer	8.19e-05	0.000742	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	8.18e-05	0.000741	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDH1—uterine cancer	8.17e-05	0.000741	CbGpPWpGaD
Boceprevir—Asthenia—Epirubicin—uterine cancer	8.11e-05	0.000278	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—HRAS—uterine cancer	8e-05	0.000725	CbGpPWpGaD
Boceprevir—Pruritus—Epirubicin—uterine cancer	8e-05	0.000274	CcSEcCtD
Boceprevir—CTSK—Immune System—CDKN1B—uterine cancer	7.75e-05	0.000703	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—KRAS—uterine cancer	7.75e-05	0.000702	CbGpPWpGaD
Boceprevir—Diarrhoea—Epirubicin—uterine cancer	7.73e-05	0.000265	CcSEcCtD
Boceprevir—Hypersensitivity—Doxorubicin—uterine cancer	7.71e-05	0.000264	CcSEcCtD
Boceprevir—CTSV—Immune System—NRAS—uterine cancer	7.69e-05	0.000697	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRAS—uterine cancer	7.69e-05	0.000697	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—HRAS—uterine cancer	7.68e-05	0.000696	CbGpPWpGaD
Boceprevir—Asthenia—Doxorubicin—uterine cancer	7.5e-05	0.000257	CcSEcCtD
Boceprevir—Dizziness—Epirubicin—uterine cancer	7.47e-05	0.000256	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—SRD5A2—uterine cancer	7.46e-05	0.000676	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NDUFB11—uterine cancer	7.46e-05	0.000676	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—KRAS—uterine cancer	7.44e-05	0.000674	CbGpPWpGaD
Boceprevir—Pruritus—Doxorubicin—uterine cancer	7.4e-05	0.000253	CcSEcCtD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—uterine cancer	7.38e-05	0.000668	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CTNNB1—uterine cancer	7.33e-05	0.000664	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL2—uterine cancer	7.29e-05	0.00066	CbGpPWpGaD
Boceprevir—Vomiting—Epirubicin—uterine cancer	7.19e-05	0.000246	CcSEcCtD
Boceprevir—Diarrhoea—Doxorubicin—uterine cancer	7.16e-05	0.000245	CcSEcCtD
Boceprevir—CTSK—Immune System—PTEN—uterine cancer	7.14e-05	0.000647	CbGpPWpGaD
Boceprevir—Rash—Epirubicin—uterine cancer	7.13e-05	0.000244	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—PIK3CA—uterine cancer	7.12e-05	0.000645	CbGpPWpGaD
Boceprevir—Dermatitis—Epirubicin—uterine cancer	7.12e-05	0.000244	CcSEcCtD
Boceprevir—Headache—Epirubicin—uterine cancer	7.08e-05	0.000243	CcSEcCtD
Boceprevir—CTSK—Innate Immune System—AKT1—uterine cancer	7.07e-05	0.00064	CbGpPWpGaD
Boceprevir—Dizziness—Doxorubicin—uterine cancer	6.92e-05	0.000237	CcSEcCtD
Boceprevir—CTSS—Immune System—ERBB2—uterine cancer	6.9e-05	0.000625	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—PIK3CA—uterine cancer	6.84e-05	0.00062	CbGpPWpGaD
Boceprevir—CTSK—Immune System—EP300—uterine cancer	6.81e-05	0.000617	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—uterine cancer	6.78e-05	0.000615	CbGpPWpGaD
Boceprevir—Nausea—Epirubicin—uterine cancer	6.71e-05	0.00023	CcSEcCtD
Boceprevir—Vomiting—Doxorubicin—uterine cancer	6.65e-05	0.000228	CcSEcCtD
Boceprevir—CTSV—Immune System—KRAS—uterine cancer	6.62e-05	0.0006	CbGpPWpGaD
Boceprevir—CTSL—Immune System—KRAS—uterine cancer	6.62e-05	0.0006	CbGpPWpGaD
Boceprevir—Rash—Doxorubicin—uterine cancer	6.59e-05	0.000226	CcSEcCtD
Boceprevir—CTSS—Innate Immune System—HRAS—uterine cancer	6.59e-05	0.000597	CbGpPWpGaD
Boceprevir—Dermatitis—Doxorubicin—uterine cancer	6.59e-05	0.000226	CcSEcCtD
Boceprevir—Headache—Doxorubicin—uterine cancer	6.55e-05	0.000224	CcSEcCtD
Boceprevir—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	6.46e-05	0.000585	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	6.44e-05	0.000583	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CDKN1B—uterine cancer	6.39e-05	0.000579	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRAS—uterine cancer	6.37e-05	0.000577	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	6.37e-05	0.000577	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—HRAS—uterine cancer	6.33e-05	0.000573	CbGpPWpGaD
Boceprevir—Nausea—Doxorubicin—uterine cancer	6.21e-05	0.000213	CcSEcCtD
Boceprevir—CTSL—Immune System—PIK3CA—uterine cancer	6.08e-05	0.000551	CbGpPWpGaD
Boceprevir—CTSV—Immune System—PIK3CA—uterine cancer	6.08e-05	0.000551	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ERBB2—uterine cancer	6.07e-05	0.00055	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CTNNB1—uterine cancer	6.03e-05	0.000547	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PTEN—uterine cancer	5.88e-05	0.000533	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—uterine cancer	5.82e-05	0.000527	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CXCL8—uterine cancer	5.76e-05	0.000522	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NDUFB11—uterine cancer	5.63e-05	0.00051	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SRD5A2—uterine cancer	5.63e-05	0.00051	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CDKN1B—uterine cancer	5.63e-05	0.00051	CbGpPWpGaD
Boceprevir—CTSL—Immune System—HRAS—uterine cancer	5.62e-05	0.00051	CbGpPWpGaD
Boceprevir—CTSV—Immune System—HRAS—uterine cancer	5.62e-05	0.00051	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EP300—uterine cancer	5.61e-05	0.000508	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—uterine cancer	5.59e-05	0.000506	CbGpPWpGaD
Boceprevir—CTSK—Immune System—KRAS—uterine cancer	5.48e-05	0.000497	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	5.43e-05	0.000492	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1B1—uterine cancer	5.4e-05	0.000489	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—STAR—uterine cancer	5.4e-05	0.000489	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CTNNB1—uterine cancer	5.31e-05	0.000482	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRAS—uterine cancer	5.25e-05	0.000475	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTEN—uterine cancer	5.18e-05	0.000469	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PIK3CA—uterine cancer	5.04e-05	0.000456	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—uterine cancer	4.97e-05	0.00045	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—uterine cancer	4.97e-05	0.00045	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EP300—uterine cancer	4.94e-05	0.000448	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.73e-05	0.000428	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—uterine cancer	4.68e-05	0.000424	CbGpPWpGaD
Boceprevir—CTSK—Immune System—HRAS—uterine cancer	4.66e-05	0.000422	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRAS—uterine cancer	4.62e-05	0.000419	CbGpPWpGaD
Boceprevir—CTSS—Immune System—KRAS—uterine cancer	4.51e-05	0.000409	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.38e-05	0.000397	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POLD1—uterine cancer	4.23e-05	0.000384	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PIK3CA—uterine cancer	4.15e-05	0.000376	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.13e-05	0.000375	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—uterine cancer	4.11e-05	0.000373	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1B1—uterine cancer	4.07e-05	0.000369	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STAR—uterine cancer	4.07e-05	0.000369	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.03e-05	0.000365	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—KRAS—uterine cancer	3.98e-05	0.00036	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1C1—uterine cancer	3.96e-05	0.000359	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.84e-05	0.000348	CbGpPWpGaD
Boceprevir—CTSS—Immune System—HRAS—uterine cancer	3.84e-05	0.000348	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PIK3CA—uterine cancer	3.65e-05	0.000331	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.64e-05	0.00033	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—uterine cancer	3.53e-05	0.00032	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—RRM2—uterine cancer	3.53e-05	0.00032	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.47e-05	0.000314	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.47e-05	0.000314	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DCN—uterine cancer	3.43e-05	0.000311	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—uterine cancer	3.39e-05	0.000307	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HRAS—uterine cancer	3.38e-05	0.000306	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP11A1—uterine cancer	3.23e-05	0.000293	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POLD1—uterine cancer	3.2e-05	0.00029	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.09e-05	0.00028	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1C3—uterine cancer	3.05e-05	0.000276	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1C1—uterine cancer	2.99e-05	0.000271	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—uterine cancer	2.98e-05	0.00027	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.84e-05	0.000258	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.75e-05	0.000249	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RRM2—uterine cancer	2.66e-05	0.000241	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DCN—uterine cancer	2.59e-05	0.000234	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STAR—uterine cancer	2.51e-05	0.000227	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.51e-05	0.000227	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP11A1—uterine cancer	2.44e-05	0.000221	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—STK11—uterine cancer	2.38e-05	0.000215	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP19A1—uterine cancer	2.38e-05	0.000215	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.32e-05	0.00021	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1C3—uterine cancer	2.3e-05	0.000208	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POLD1—uterine cancer	1.97e-05	0.000178	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.84e-05	0.000167	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP19A1—uterine cancer	1.79e-05	0.000162	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STK11—uterine cancer	1.79e-05	0.000162	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—uterine cancer	1.79e-05	0.000162	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RRM2—uterine cancer	1.64e-05	0.000149	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DCN—uterine cancer	1.59e-05	0.000144	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.5e-05	0.000136	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.42e-05	0.000128	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—uterine cancer	1.35e-05	0.000122	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.1e-05	0.0001	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STK11—uterine cancer	1.1e-05	0.0001	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTEN—uterine cancer	9.93e-06	9e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—EP300—uterine cancer	9.47e-06	8.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—uterine cancer	8.3e-06	7.52e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTEN—uterine cancer	7.49e-06	6.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—EP300—uterine cancer	7.15e-06	6.48e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3CA—uterine cancer	7.01e-06	6.35e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—uterine cancer	5.72e-06	5.19e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3CA—uterine cancer	5.29e-06	4.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTEN—uterine cancer	4.62e-06	4.18e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—EP300—uterine cancer	4.4e-06	3.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—uterine cancer	4.32e-06	3.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.26e-06	2.95e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—uterine cancer	2.66e-06	2.41e-05	CbGpPWpGaD
